Standard
Basal insulin and cardiovascular and other outcomes in dysglycemia. / Gerstein, Hertzel C; Bosch, Jackie; Dagenais, Gilles R; Díaz, Rafael; Jung, Hyejung; Maggioni, Aldo P; Pogue, Janice; Probstfield, Jeffrey; Ramachandran, Ambady; Riddle, Matthew C; Rydén, Lars E; Yusuf, Salim; ORIGIN Trial Investigators; Krarup, Thure; Perrild, Hans Jørgen Duckert; Torp-Pedersen, Christian Tobias.
In:
New England Journal of Medicine, Vol. 367, No. 4, 2012, p. 319-28.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Gerstein, HC, Bosch, J, Dagenais, GR, Díaz, R, Jung, H, Maggioni, AP, Pogue, J, Probstfield, J, Ramachandran, A, Riddle, MC, Rydén, LE, Yusuf, S, ORIGIN Trial Investigators, Krarup, T
, Perrild, HJD & Torp-Pedersen, CT 2012, '
Basal insulin and cardiovascular and other outcomes in dysglycemia',
New England Journal of Medicine, vol. 367, no. 4, pp. 319-28.
https://doi.org/10.1056/NEJMoa1203858APA
Gerstein, H. C., Bosch, J., Dagenais, G. R., Díaz, R., Jung, H., Maggioni, A. P., Pogue, J., Probstfield, J., Ramachandran, A., Riddle, M. C., Rydén, L. E., Yusuf, S., ORIGIN Trial Investigators, Krarup, T.
, Perrild, H. J. D., & Torp-Pedersen, C. T. (2012).
Basal insulin and cardiovascular and other outcomes in dysglycemia.
New England Journal of Medicine,
367(4), 319-28.
https://doi.org/10.1056/NEJMoa1203858Vancouver
Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP et al.
Basal insulin and cardiovascular and other outcomes in dysglycemia.
New England Journal of Medicine. 2012;367(4):319-28.
https://doi.org/10.1056/NEJMoa1203858Author
Gerstein, Hertzel C ; Bosch, Jackie ; Dagenais, Gilles R ; Díaz, Rafael ; Jung, Hyejung ; Maggioni, Aldo P ; Pogue, Janice ; Probstfield, Jeffrey ; Ramachandran, Ambady ; Riddle, Matthew C ; Rydén, Lars E ; Yusuf, Salim ; ORIGIN Trial Investigators ; Krarup, Thure ; Perrild, Hans Jørgen Duckert ; Torp-Pedersen, Christian Tobias. / Basal insulin and cardiovascular and other outcomes in dysglycemia. In: New England Journal of Medicine. 2012 ; Vol. 367, No. 4. pp. 319-28.
Bibtex
@article{46b6ccc5b8ea4ad9a7b8c35718ffa9ad,
title = "Basal insulin and cardiovascular and other outcomes in dysglycemia",
abstract = "The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested.",
author = "Gerstein, {Hertzel C} and Jackie Bosch and Dagenais, {Gilles R} and Rafael D{\'i}az and Hyejung Jung and Maggioni, {Aldo P} and Janice Pogue and Jeffrey Probstfield and Ambady Ramachandran and Riddle, {Matthew C} and Ryd{\'e}n, {Lars E} and Salim Yusuf and Torp-Pedersen, {Christian Tobias} and Thure Krarup and Perrild, {Hans J{\o}rgen Duckert} and Torp-Pedersen, {Christian Tobias}",
year = "2012",
doi = "10.1056/NEJMoa1203858",
language = "English",
volume = "367",
pages = "319--28",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachusetts Medical Society",
number = "4",
}
RIS
TY - JOUR
T1 - Basal insulin and cardiovascular and other outcomes in dysglycemia
AU - Gerstein, Hertzel C
AU - Bosch, Jackie
AU - Dagenais, Gilles R
AU - Díaz, Rafael
AU - Jung, Hyejung
AU - Maggioni, Aldo P
AU - Pogue, Janice
AU - Probstfield, Jeffrey
AU - Ramachandran, Ambady
AU - Riddle, Matthew C
AU - Rydén, Lars E
AU - Yusuf, Salim
AU - ORIGIN Trial Investigators
AU - Krarup, Thure
AU - Perrild, Hans Jørgen Duckert
AU - Torp-Pedersen, Christian Tobias
PY - 2012
Y1 - 2012
N2 - The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested.
AB - The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested.
U2 - 10.1056/NEJMoa1203858
DO - 10.1056/NEJMoa1203858
M3 - Journal article
C2 - 22686416
VL - 367
SP - 319
EP - 328
JO - New England Journal of Medicine
JF - New England Journal of Medicine
SN - 0028-4793
IS - 4
ER -
